Anita Katalin Göndör

• Fonseca, Pedro; Cui, Weiyingqi; Struyf, Nona; Tong, Le; Chaurasiya, Ayushi & Casagrande, Felipe [Vis alle 16 forfattere av denne artikkelen] (2024). A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells. Journal of Experimental & Clinical Cancer Research. 43(1). doi: 10.1186/s13046-024-03031-w. Fulltekst i vitenarkiv Vis sammendrag

  Background Tumor cells have the ability to invade and form small clusters that protrude into adjacent tissues, a phenomenon that is frequently observed at the periphery of a tumor as it expands into healthy tissues. The presence of these clusters is linked to poor prognosis and has proven challenging to treat using conventional therapies. We previously reported that p60AmotL2 expression is localized to invasive colon and breast cancer cells. In vitro, p60AmotL2 promotes epithelial cell invasion by negatively impacting E-cadherin/AmotL2-related mechanotransduction. Methods Using epithelial cells transfected with inducible p60AmotL2, we employed a phenotypic drug screening approach to find compounds that specifically target invasive cells. The phenotypic screen was performed by treating cells for 72 h with a library of compounds with known antitumor activities in a dose-dependent manner. After assessing cell viability using CellTiter-Glo, drug sensitivity scores for each compound were calculated. Candidate hit compounds with a higher drug sensitivity score for p60AmotL2-expressing cells were then validated on lung and colon cell models, both in 2D and in 3D, and on colon cancer patient-derived organoids. Nascent RNA sequencing was performed after BET inhibition to analyse BET-dependent pathways in p60AmotL2-expressing cells. Results We identified 60 compounds that selectively targeted p60AmotL2-expressing cells. Intriguingly, these compounds were classified into two major categories: Epidermal Growth Factor Receptor (EGFR) inhibitors and Bromodomain and Extra-Terminal motif (BET) inhibitors. The latter consistently demonstrated antitumor activity in human cancer cell models, as well as in organoids derived from colon cancer patients. BET inhibition led to a shift towards the upregulation of pro-apoptotic pathways specifically in p60AmotL2-expressing cells. Conclusions BET inhibitors specifically target p60AmotL2-expressing invasive cancer cells, likely by exploiting differences in chromatin accessibility, leading to cell death. Additionally, our findings support the use of this phenotypic strategy to discover novel compounds that can exploit vulnerabilities and specifically target invasive cancer cells.

• Vestlund, Johanna; Sumida, Noriyuki; Mehmood, Rashid; Bhartiya, Deeksha; Wu, Shuangyang & Göndör, Anita (2022). The Nodewalk assay to quantitate chromatin fiber interactomes in very small cell populations. Nature Protocols. ISSN 1754-2189. doi: 10.1038/s41596-022-00774-8. Fulltekst i vitenarkiv
• Chachoua, Ilyas; Tzelepis, Ilias; Dai, Hao; Lim, Jia Pei; Ronnegren, Anna Lewandowska & Casagrande, Felipe Beccaria [Vis alle 14 forfattere av denne artikkelen] (2022). Canonical WNT signaling-dependent gating of MYC requires a noncanonical CTCF function at a distal binding site. Nature Communications. doi: 10.1038/s41467-021-27868-3. Fulltekst i vitenarkiv

Se alle arbeider i NVA